IL22RA1 and colitis: This was evidenced by the limited hemopexin induction in the liver and its reduced presence in the serum and feces of Il-22ra1-/- mice and by the consequent severity of DSS-induced colitis, which could be reversed by recombinant hemopexin treatment.